The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Switching Apoptosis to Ferroptosis: Metal–Organic Network for High-Efficiency Anticancer Therapy
Abstract
Discovering advanced materials for regulating cell death is of great importance in the development of anticancer therapy. Herein, by harnessing the recently discovered oxidative stress regulation ability of p53 and the Fenton reaction inducing capability of metal-organic network (MON), MON encapsulated with p53 plasmid (MON-p53) was designed to eradicate cancer cells via ferroptosis/apoptosis hybrid pathway. After confirming the detailed mechanism of MON-p53 in evoking ferroptosis, we further discovered that MON-p53 mediated a "bystander effect" to further sensitize cancer cells toward the MON-p53 induced ferroptosis. A 75-day anticancer experiment indicated that MON-p53 treatment not only suppressed the tumor growth but also prolonged the life-span of tumor bearing mice. Owing to its ability to promote intracellular oxidative stress, MON-p53 decreased the blood metastasis, lung metastasis, and liver metastasis. As a consequence, discovering methods to induce cell ferroptosis would provide a new insight in designing anticancer materials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
One-Step Assembly of Coordination Complexes for Versatile Film and Particle Engineering
Ejima, H., Richardson, J. J., Liang, K., Best, J. P., van Koeverden, M. P., Such, G. K., Cui, J., & Caruso, F. (2013) · Science · doi:10.1126/science.1237265 · Cited by 2,419
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Zhang, C., Bu, W., Ni, D., Zhang, S., Li, Q., Yao, Z., Zhang, J., Yao, H., Wang, Z., & Shi, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510031 · Cited by 1,269
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Iron-Clad Fibers: A Metal-Based Biological Strategy for Hard Flexible Coatings
Harrington, M. J., Masic, A., Holten-Andersen, N., Waite, J. H., & Fratzl, P. (2010) · Science · doi:10.1126/science.1181044 · Cited by 1,000
T cell lipid peroxidation induces ferroptosis and prevents immunity to infection
Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G. W., & Kopf, M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140857 · Cited by 672
Zheng, D.-W., Li, B., Li, C.-X., Fan, J.-X., Lei, Q., Li, C., Xu, Z., & Zhang, X.-Z. (2016) · ACS Nano · doi:10.1021/acsnano.6b04156 · Cited by 663
Self-citationLiu, H., Patel, M. R., Prescher, J. A., Patsialou, A., Qian, D., Lin, J., Wen, S., Chang, Y.-F., Bachmann, M. H., Shimono, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006732107 · Cited by 465
Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., Feng, B., Zhou, F., Fu, Y., Yin, Q., Zhang, P., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01994 · Cited by 405
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
Maute, R. L., Gordon, S. R., Mayer, A. T., McCracken, M. N., Natarajan, A., Ring, N. G., Kimura, R., Tsai, J. M., Manglik, A., Kruse, A. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519623112 · Cited by 347
Li, H., Li, Y., Jiao, J., & Hu, H.-M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.153 · Cited by 347
Azzam, E. I., Toledo, S. M. D., Spitz, D. R., & Little, J. B. (2002) · PubMed · Cited by 328
Yu, L., Chen, Y., Wu, M., Cai, X., Yao, H., Zhang, L., Chen, H., & Shi, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04299 · Cited by 305
Yuan, Y., Liu, J., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402189 · Cited by 302
Shimada, K., Hayano, M., Pagano, N. C., & Stockwell, B. R. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.11.016 · Cited by 297
Wang, X.-G., Dong, Z.-Y., Cheng, H., Wan, S.-S., Chen, W.-H., Zou, M.-Z., Huo, J.-W., Deng, H.-X., & Zhang, X.-Z. (2015) · Nanoscale · doi:10.1039/c5nr04045k · Cited by 291
Self-citationRAC1 P29S is a spontaneously activating cancer-associated GTPase
Davis, M. J., Ha, B. H., Holman, E. C., Halaban, R., Schlessinger, J., & Boggon, T. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220895110 · Cited by 180
Zhang, Y., Zheng, F., Yang, T., Zhou, W., Liu, Y., Man, N., Zhang, L., Jin, N., Dou, Q., Zhang, Y., et al. (2012) · Nature Materials · doi:10.1038/nmat3363 · Cited by 179
Cabral, H., Makino, J., Matsumoto, Y., Mi, P., Wu, H., Nomoto, T., Toh, K., Yamada, N., Higuchi, Y., Konishi, S., et al. (2015) · ACS Nano · doi:10.1021/nn5070259 · Cited by 159
Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties
Hofmans, S., Berghe, T. V., Devisscher, L., Hassannia, B., Lyssens, S., Joossens, J., der Veken, P. V., Vandenabeele, P., & Augustyns, K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01641 · Cited by 146
Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy
Zheng, D., Chen, J., Zhu, J., Rong, L., Li, B., Lei, Q., Fan, J., Zou, M., Li, C., Cheng, S., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01432 · Cited by 117
Self-citationHan, K., Lei, Q., Jia, H., Wang, S., Yin, W., Chen, W., Cheng, S., & Zhang, X. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201403190 · Cited by 113
Self-citationUsing Plasmonic Copper Sulfide Nanocrystals as Smart Light-Driven Sterilants
Liu, Z., Liu, X., Du, Y., Ren, J., & Qu, X. (2015) · ACS Nano · doi:10.1021/acsnano.5b04380 · Cited by 104
Bollineni, R. C., Hoffmann, R., & Fedorova, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.030 · Cited by 65
Ruenraroengsak, P., Chen, S., Hu, S., Melbourne, J., Sweeney, S. S., Thorley, A. J., Skepper, J. N., Shaffer, M. S. P., Tetley, T. D., & Porter, A. E. (2016) · ACS Nano · doi:10.1021/acsnano.5b08218 · Cited by 33
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201805664 · Cited by 1,951
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Mou, Y., Wang, J., Wu, J., He, D., Zhang, C., Duan, C., & Li, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0720-y · Cited by 1,930
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Self-citationRole of GPX4 in ferroptosis and its pharmacological implication
Seibt, T. M., Proneth, B., & Conrad, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.014 · Cited by 1,520
Metadata
- Authors
- Zheng, D.-W., Lei, Q., Zhu, J.-Y., Fan, J.-X., Li, C.-X., Li, C., Xu, Z., Cheng, S.-X., & Zhang, X.-Z.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-29
- Volume
- 17
- Issue
- 1
- Pages
- 284-291
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2566397909
- Cited by
- 434
- References
- 31
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.